Snakebites in Pediatric Patients in Kahramanmaraş: Is Pro-brain Natriuretic Peptide a Prognostic Biomarker for Snakebites?
antivenom
complex regional pain syndrome
pediatric
probnp
snakebite
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
accepted:
24
01
2022
entrez:
1
3
2022
pubmed:
2
3
2022
medline:
2
3
2022
Statut:
epublish
Résumé
Snake envenomations are a serious cause of mortality and morbidity in the world. This study was conducted to investigate snake bites in pediatric patients in Kahramanmaraş and to determine whether pro-brain natriuretic peptide (proBNP) has a prognostic value in these patients. Pediatric patients aged <18 years who presented to the pediatric emergency department with snakebites were reviewed retrospectively. The demographical, clinical, laboratory, treatments, and outcomes data were collected from their medical records. Stage 0 and 1 envenomation was considered as a non-serious complication and stage 2 and 3 envenomation was considered as a serious complication. A total of 32 pediatric patients, six females and 26 males, between 2016 and 2021, were included in the study. The mean age was 12.52±3.28 years. There were seven patients without serious complications and 25 patients with serious complications. The best cutoff point for proBNP to predict serious complications was found to be ≥272.5 ng∙L In this study, proBNP was shown to be predictive of a poor outcome of snakebites. Moreover, complex regional pain syndrome, which is rarely reported in the literature, should be kept in mind during the long-term follow-up of snakebites.
Sections du résumé
BACKGROUND
BACKGROUND
Snake envenomations are a serious cause of mortality and morbidity in the world.
AIMS
OBJECTIVE
This study was conducted to investigate snake bites in pediatric patients in Kahramanmaraş and to determine whether pro-brain natriuretic peptide (proBNP) has a prognostic value in these patients.
METHODS
METHODS
Pediatric patients aged <18 years who presented to the pediatric emergency department with snakebites were reviewed retrospectively. The demographical, clinical, laboratory, treatments, and outcomes data were collected from their medical records. Stage 0 and 1 envenomation was considered as a non-serious complication and stage 2 and 3 envenomation was considered as a serious complication.
RESULTS
RESULTS
A total of 32 pediatric patients, six females and 26 males, between 2016 and 2021, were included in the study. The mean age was 12.52±3.28 years. There were seven patients without serious complications and 25 patients with serious complications. The best cutoff point for proBNP to predict serious complications was found to be ≥272.5 ng∙L
CONCLUSIONS
CONCLUSIONS
In this study, proBNP was shown to be predictive of a poor outcome of snakebites. Moreover, complex regional pain syndrome, which is rarely reported in the literature, should be kept in mind during the long-term follow-up of snakebites.
Identifiants
pubmed: 35228929
doi: 10.7759/cureus.21570
pmc: PMC8866160
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e21570Informations de copyright
Copyright © 2022, İpek et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Intensive Care. 2021 Apr 26;9(1):36
pubmed: 33902707
Wilderness Environ Med. 2021 Sep;32(3):284-292
pubmed: 34172373
Int Health. 2011 Mar;3(1):50-5
pubmed: 24038050
SAGE Open Med Case Rep. 2021 Apr 10;9:2050313X211007705
pubmed: 33953917
Toxins (Basel). 2018 Nov 14;10(11):
pubmed: 30441876
Dis Mon. 2020 Aug;66(8):101015
pubmed: 32532456
Eur Rev Med Pharmacol Sci. 2015;19(14):2711-6
pubmed: 26221904
Wilderness Environ Med. 2021 Jun;32(2):137-142
pubmed: 33994108
Int Med Case Rep J. 2020 Nov 10;13:603-607
pubmed: 33204179
Pain. 2004 Mar;108(1-2):180-91
pubmed: 15109522
Clin Toxicol (Phila). 2021 Oct;59(10):905-912
pubmed: 33641566
Adv Med Sci. 2020 Sep;65(2):310-315
pubmed: 32505856
Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H368-76
pubmed: 11123253
Wilderness Environ Med. 2018 Dec;29(4):437-445
pubmed: 30292560
Am J Trop Med Hyg. 2020 Dec 14;104(3):1142-1148
pubmed: 33319738
Am J Emerg Med. 2021 Oct;48:307-311
pubmed: 34246919
Ulus Travma Acil Cerrahi Derg. 2010 May;16(3):210-4
pubmed: 20517744
J Pediatr Surg. 2014 Aug;49(8):1295-9
pubmed: 25092093
Arch Dis Child. 2021 Jan;106(1):14-19
pubmed: 33115713
J Pediatr. 2020 May;220:14-20.e4
pubmed: 31955879
J Trop Pediatr. 2021 Jul 2;67(3):
pubmed: 34213542
Wilderness Environ Med. 2020 Jun;31(2):131-143
pubmed: 32336579
Toxicon. 2016 Mar 15;112:8-15
pubmed: 26802624
Rev Inst Med Trop Sao Paulo. 2010 Jul-Aug;52(4):215-20
pubmed: 21748231
J Biol Eng. 2018 Jan 12;12:2
pubmed: 29344085